We are live on ! Find out more
AKBA icon

Akebia Therapeutics
AKBA

91 hedge funds and large institutions have $189M invested in Akebia Therapeutics in 2016 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 46 increasing their positions, 21 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

119% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 21

26% more call options, than puts

Call options by funds: $1.82M | Put options by funds: $1.45M

1% more funds holding

Funds holding: 90 → 91 (+1)

7% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 15

10% less capital invested

Capital invested by funds: $209M → $189M (-$20M)

Holders
91
Holders Change
+1
Holders Change %
+1.11%
% of All Funds
2.42%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
16
Increased
46
Reduced
21
Closed
15
Calls
$1.82M
Puts
$1.45M
Net Calls
+$374K
Net Calls Change
-$696K

Top Buyers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
+$9.13M
2
First Manhattan
First Manhattan
New York
+$8.69M
3
PA
Perceptive Advisors
New York
+$4.91M
4
Bank of America
Bank of America
North Carolina
+$3.36M
5
VAM
Visium Asset Management
New York
+$3.28M

Top Sellers

Rank Fund Capital Flow
1
EI
EAM Investors
California
-$4.92M
2
Millennium Management
Millennium Management
New York
-$3.65M
3
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$2.43M
4
Ameriprise
Ameriprise
Minnesota
-$2.41M
5
PAM
Panagora Asset Management
Massachusetts
-$1.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$830K +$64.5K +7,954 +9%
Wells Fargo
27
Wells Fargo
California
$784K -$41.3K -5,094 -6%
BCM
28
Bridgeway Capital Management
Texas
$732K -$125K -15,400 -16%
UBS Group
29
UBS Group
Switzerland
$679K -$127K -15,623 -17%
Invesco
30
Invesco
Georgia
$618K +$556K +68,611 New
Connor, Clark & Lunn Investment Management (CC&L)
31
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$614K -$241K -29,725 -30%
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$612K +$161K +19,909 +41%
DCM
33
DAFNA Capital Management
California
$592K +$533K +65,700 New
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$532K – – –
TA
35
Teachers Advisors
New York
$489K +$154K +19,049 +54%
ERSOT
36
Employees Retirement System of Texas
Texas
$451K – – –
Creative Planning
37
Creative Planning
Kansas
$451K +$203K +25,000 +100%
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$405K +$98.2K +12,110 +37%
AA
39
ALPS Advisors
Colorado
$384K +$18.4K +2,270 +6%
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$379K +$113K +13,880 +49%
MLICM
41
Metropolitan Life Insurance Company (MetLife)
New York
$306K +$124K +15,346 +82%
ProShare Advisors
42
ProShare Advisors
Maryland
$287K +$27.8K +3,429 +12%
SIP
43
Stoneridge Investment Partners
Pennsylvania
$273K +$88.6K +10,922 +56%
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
$272K -$137K -16,852 -36%
Renaissance Technologies
45
Renaissance Technologies
New York
$257K -$654K -80,700 -74%
D.E. Shaw & Co
46
D.E. Shaw & Co
New York
$250K +$225K +27,700 New
Dimensional Fund Advisors
47
Dimensional Fund Advisors
Texas
$226K +$34.9K +4,300 +21%
CG
48
Cutler Group
California
$225K +$123K +15,109 +153%
RJA
49
Raymond James & Associates
Florida
$209K -$6.2K -764 -3%
Citigroup
50
Citigroup
New York
$208K +$112K +13,758 +147%
1
2
3 4 5

AKBA Hedge Fund Activity: Q1 2016 in Review

91 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Akebia Therapeutics (AKBA) for Q1 2016, worth a combined $189M — down 9.6% from $209M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new AKBA positions and 15 closed out — a net gain of 1 holder — while 46 added to existing stakes and 21 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $9.13M. The largest seller was EAM Investors, exiting entirely with an estimated $4.92M sold.

  • 91 institutional investors held Akebia Therapeutics (AKBA) as of Q1 2016, up from 90 in Q4 2015.
  • Funds reported $189M of Akebia Therapeutics stock for Q1 2016, down 9.6% quarter-over-quarter.
  • 16 funds opened new Akebia Therapeutics positions in Q1 2016 and 15 closed out, a net change of +1 holder.
  • The largest Akebia Therapeutics buyer in Q1 2016 was Nantahala Capital Management, an estimated $9.13M added.
  • The largest Akebia Therapeutics seller in Q1 2016 was EAM Investors, an estimated $4.92M sold.

Based on aggregated 13F filings for Q1 2016.